| ○ |
|
脇田 隆字 |
国立感染所・所長 |
| ウイルス学、肝炎ウイルス学 |
| Wakita T, T Pietschmann, T Kato, T Date, M Miyamoto, Z Zhao, K Murthy, A Habermann, H-G Krausslich, M Mizokami, R Bartenschlager, T J Liang. Production of Infectious Hepatitis C Virus in Tissue Culture from a Cloned Viral Genome. Nat Med. 2005 11:791-6.
|
| Wakita T and Wands JR. Specific inhibition of hepatitis C virus expression by antisense oligodeoxy-nucleotides: In vitro model for selection of target sequence. J Biol Chem. 1994 269:14205-10
|
| Wakita T, Kakumu S, Shibayama M, Yoshioka K, Ito Y, Shinagawa T, Ishikawa T, Takayanagi M, Morishima T. Detection of pre-C and core region mutants of hepatitis B virus in chronic hepatitis B virus carriers. J Clin Invest. 1991 88: 1793-801
|
|
| |
|
喜田 宏 |
北海道大学人獣共通感染症国際共同研究所 特別招聘教授 統括
|
| ウイルス学、人獣共通感染症学、ワクチン学 |
| 「人獣共通感染症 改訂３版」 喜田 宏 他 共著, 木村 哲/喜田 宏 編, 医薬ジャーナル社 (2016)
|
| 1. Sekiya T, Mifsud EJ, Ohno M, Nomura N, Sasada M, Fujikura D, Daito T, Shingai M, Ohara Y, Nishimura T, Endo M, Mitsumata R, Ikeda T, Hatanaka H, Kitayama H, Motokawa K, Sobue T, Suzuki S, Itoh Y, Brown LE, Ogasawara K, Kino Y, Kida H. (2019) Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 production is ideal for influenza. Vaccine 37(15): 2158-2166.
|
| Ohno M, Sekiya T, Nomura N, Daito TJ, Shingai M, Kida H. (2020) Influenza virus infection affects insulin signaling, fatty acid-metabolizing enzyme expressions, and the tricarboxylic acid cycle in mice. Sci Rep. 2;10(1):10879.
|
|
| |
|
遠藤 弘良 |
聖路加国際大学名誉教授 |
| 公衆衛生学、国際保健 |
（研究論文）
S.Miyano,G.Syakantu, K.Komada, H.Endo, T.Sugishita, Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia, Cost Effectiveness and Resource Allocation, 2017, 15:4,
|
（研究論文）
W.Paoin, M.Yuenyongsuwan, Y.Yokobori, H.Endo, S.Kim, Development of the ICD-10 simplified version and field test, Professional practice and innovation, 2017
|
（報告書）
F.Harvey,H.Endo et al., A report by the Independent Oversight and Advisory Committee for the WHO Health Emergency Programme, 2019
|
|
| |
| 山崎晋一朗 |
千葉県病院局副病院局長 |
| 専門分野：医療行政 |
特になし |
（業績・実績その２） |
（業績・実績その３） |
|
| |
|
小池 和彦 |
関東中央病院・病院長 |
| 専門分野 内科学、感染症、消化器 |
| 1 Hirano J, Yoshio S, Sakai Y, Songling L, Suzuki T, Itoh Y, Zhang H, Chen DV, Haga S, Oomori H, Kodama T, Maeda Y, Ono Y, Takahashi Y, Standley DM, Yamamoto M, Moriishi K, Moriya K, Kanto T, Takehara T, Koike K, Matsuura Y, Okamoto T. Hepatitis C virus modulates signal peptide peptidase to alter host protein processing. Proc Natl Acad Sci U S A 2021 Jun 1;118(22):e2026184118. doi:10.1073/pnas.2026184118. PMID: 34035171.
|
| 2 Okamoto K, Hatakeyama S, Itoyama S, Nukui Y, Yoshino Y, Kitazawa T, Yotsuyanagi H, Reiko Ikeda, SugitaT, Koike K. Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 2010;16:1155-1157.
|
| 3 Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y. Emergence of Influenza B Viruses With Reduced Sensitivity to Neuraminidase Inhibitors. JAMA 2007;297:1435-1442.
|
|
| |
|
笹川 千尋 |
千葉大学真菌医学研究センター・センター長
一般財団法人日本生物科学研究所・所長
（東京大学名誉教授）
|
| 微生物学、感染症学、免疫学 |
| Isolation and characterization of Helicobacter suis from huma stomach. Rimbara E, Suzuki M, Matsui H, Nakamura M, Morimoto M, Sasakawa C, Matsuda H, Nomura S, Osaki T, Nagata N, Shibayama K, Tokunaga K. Proc Natl Acad Sci USA. 2021 Mar; 118(13):e2026337118.doi.
|
| An update on the regulatory mechanisms of NLRP3 inflammasome activation. Palk S, Kim JK, Silwal P, Jo EK. Cell Mol Immunol. 2021 May; 18:1141-1160.
|
| Shigella infection and host cell death: a double-edged sword for the host and pathogen survival. Ashida H, Suzuki T, Sasakawa C. Curr Opin Microbiol. 2021. Feb; 59:1-7.
|
|
| |
|
髙子 徹 |
AMED 科学技術顧問 |
| 薬理、創薬科学 |
| Affinity and kinetic analysis of the molecular interaction of ICAM-1 and leukocyte function-associated antigen-1.: Tominaga Y, Kita Y, Satoh A, Asai S, Kato K, Ishikawa K, Horiuchi T, Takashi T. , J. Immunol. 1998, 161(8), 4016-4022
|
| Development of a cell-free binding assay for a rat ICAM-1/LFA-1 interactions using a novel anti-rat LFA-1 monoclonal antibody and comparison with a cell-based assay.: Mukasa R, Satoh A, Tominaga Y, Yamazaki M, Matsumoto K, Iigo Y, Higashida T, Kita Y, Miyasaka M, Takashi T. , J. Immumol. Methods. 1999, 228(1-2), 69-79
|
Discovery of trans-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]
acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.: Muro F, Iimura S, Sugimoto Y, Yoneda Y, Chiba J, Watanabe T, Setoguchi M, Iigo Y, Matsumoto K, Satoh A, Takayama G, Taira T, Yokoyama M, Takashi T, Nakayama A, Machinaga N., J. Med. Chem. 2009, 52(24), 7974-7992
|
|
| |
|
堀田 博 |
甲南女子大学医療栄養学部・教授
（神戸大学・名誉教授）
|
| 専門分野：ウイルス学、微生物感染症学 |
| Miyashita M, Mitani N, Kitanaka A, Yakio M, Chen M, Nishimoto S, Uchiyama H, Sue M, Hotta H, Nakagawa Y, Miyagawa. Identification of an antiviral component from the venom of the scorpion Liocheles australasiae using venom gland transcriptome analysis. Toxicon. 2021 Feb; 191(2), 25-37.
|
| Peroxiredoxin 1, a novel HBx-interacting protein, interacts with Exosc5 and negatively regulates HBV propagation through degradation of HBV RNA. Deng L, Gan X, Ito M, Chen M, Aly HH, Matsui C, Abe T, Watashi K, Wakita T, Suzuki T, Okamoto T, Matsuura Y, Mizokami M, Shoji I, Hotta H. J Virol. 2019 Mar 5; 93(6): e02203-18.
|
| 医学教科書「コンパクト微生物学 改訂第5版」小熊惠二, 堀田博 (監修), 林俊治, 石戸聡 (編集), 南江堂, (2021).
|
|
| |
|
森 亨 |
（公財）結核予防会結核研究所名誉所長 |
| 結核病学 |
| Mori T, Ishikawa N: Tuberculosis in Japan before, during and after World War II, (in: Murray JF, Loddenkemper R (eds): Tuberculosis and War. Lessons Learned from World War II. Karger, 2018)
|
| 國分恵子・堀口美奈子・森 亨：認知症患者の生命予後：日本の一地域の介護保険認定者における観察．日本公衛誌 67(5): 319-326, 2020
|
| 森 亨・岡輝明：剖検記録からみた最近の結核臨床診断の精度．結核 96(1): 1-5, 2021
|
|
